{
    "name": "Factor IX complex",
    "comment": "Rx",
    "other_names": [
        "Bebulin",
        "Profilnine SD",
        "Bebulin VH"
    ],
    "classes": [
        "Coagulation Factors",
        "Hemostatics"
    ],
    "source": "https://reference.medscape.com/drug/bebulin-vh-profilnine-sd-factor-ix-complex-999858",
    "pregnancy": {
        "common": [
            "Pregnancy Category: C",
            "Lactation: Unknown if distributed in human breast milk"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: Unknown if distributed in human breast milk"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity",
                "Bebulin, Bebulin VH: Known allergy to heparin or history of heparin-induced thrombocytopenia"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Made from pooled human plasma, it may carry a risk of transmitting infectious agents (eg, viruses), and theoretically, the Creutzfeldt-Jakob disease (CJD) agent",
                "Thromboembolic events (DVT, PE, thrombotic stroke) as well as DIC reported",
                "Factor IX complex products may partically counteract the effect of warfarin treatment; does NOT include adequate FVII levels to be used to reverse warfarin-induced bleeding",
                "Formation of circulating antibodies inhibiting Factor IX reported"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Serious",
            "interaction_with": "tranexamic acid oral",
            "description": {
                "common": "tranexamic acid oral, Factor IX complex.\nEither increases toxicity of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Coadministration may increase risk for thrombosis."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Formation of circulating antibodies inhibiting Factor IX",
            "percent": null
        },
        {
            "name": "Blood and lymphatic system disorders",
            "percent": null
        },
        {
            "name": "Disseminated intravascular coagulation",
            "percent": null
        },
        {
            "name": "Immune system disorder",
            "percent": null
        },
        {
            "name": "Anaphylactic",
            "percent": null
        },
        {
            "name": "anaphylactoid reactions",
            "percent": null
        },
        {
            "name": "hypersensitivity",
            "percent": null
        },
        {
            "name": "Nervous system disorders",
            "percent": null
        },
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "Cardiac disorders",
            "percent": null
        },
        {
            "name": "Tachycardia",
            "percent": null
        },
        {
            "name": "Vascular disorders",
            "percent": null
        },
        {
            "name": "Thromboembolic events",
            "percent": null
        },
        {
            "name": "including DVT",
            "percent": null
        },
        {
            "name": "PE",
            "percent": null
        },
        {
            "name": "thrombotic stroke",
            "percent": null
        },
        {
            "name": "flushing",
            "percent": null
        },
        {
            "name": "Respiratory",
            "percent": null
        },
        {
            "name": "thoracic",
            "percent": null
        },
        {
            "name": "and mediastinal disorders",
            "percent": null
        },
        {
            "name": "Dyspnea",
            "percent": null
        },
        {
            "name": "bronchospasm",
            "percent": null
        },
        {
            "name": "wheezing",
            "percent": null
        },
        {
            "name": "cough",
            "percent": null
        },
        {
            "name": "Gastrointestinal disorders",
            "percent": null
        },
        {
            "name": "Abdominal pain",
            "percent": null
        },
        {
            "name": "nausea",
            "percent": null
        },
        {
            "name": "Skin and subcutaneous tissue disorders",
            "percent": null
        },
        {
            "name": "Angioedema",
            "percent": null
        },
        {
            "name": "facial edema",
            "percent": null
        },
        {
            "name": "rash",
            "percent": null
        },
        {
            "name": "pruritus",
            "percent": null
        },
        {
            "name": "Renal and urinary disorders",
            "percent": null
        },
        {
            "name": "Nephrotic syndrome",
            "percent": null
        },
        {
            "name": "General disorders and administration site conditions",
            "percent": null
        },
        {
            "name": "Infusion site reactions",
            "percent": null
        },
        {
            "name": "including pain at infusion site",
            "percent": null
        }
    ]
}